These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 517249)

  • 1. A clinical study on urinary kallikrein in patients with renal diseases.
    Kimura K; Onodera K; Oike Y; Yamabe H; Numahata H; Kikuchi K; Hanada S
    Adv Exp Med Biol; 1979; 120B():549-59. PubMed ID: 517249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum and urinary arginine-esterase activity in paediatric kidney diseases.
    Turi S; Németh I; Bodrogi T
    Acta Paediatr Hung; 1984; 25(4):399-407. PubMed ID: 6570088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary kallikrein excretion in glomerulonephritis and nephrotic syndrome.
    Cumming AD; Robson JS
    Nephron; 1985; 39(3):206-10. PubMed ID: 3844632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A substrate inhibitor analysis of the urinary excretion of tissue and plasma kallikreins in patients with chronic glomerulonephritis].
    Platonova LV; Poliantseva LR; Filatova MP; Paskhina TS
    Urol Nefrol (Mosk); 1990; (4):38-43. PubMed ID: 2275058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diurnal urinary excretion of kallikrein in nephropathy patients].
    Kuznetsov VA; Poliantseva LR; Bol'shakova TD; Paskhina TS
    Sov Med; 1986; (2):44-8. PubMed ID: 3635288
    [No Abstract]   [Full Text] [Related]  

  • 6. Urinary kallikrein excretion in chronic renal disease with respect to salt intake and renal reserve.
    Tsai TJ; Su CJ; Chen YM; Hsieh BS; Chen WY; Yen TS
    J Formos Med Assoc; 1991 Jun; 90(6):525-30. PubMed ID: 1680995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship between urinary alpha-glucosidase and some indices of kidney function in several medical nephropathies. Preliminary report].
    Ceriotti G; Guarnieri GF; Bonini PA; Huber W; Campanacci L
    Quad Sclavo Diagn; 1972 Mar; 8(1):155-63. PubMed ID: 4663750
    [No Abstract]   [Full Text] [Related]  

  • 8. [Urinary excretion of kallikrein in glomerulonephritis].
    Cannella G; Baggio B; Antonello A; Favaro S; Todesco S; Borsatti A; Campanacci L
    Boll Soc Ital Biol Sper; 1973 May; 49(10):580-5. PubMed ID: 4788779
    [No Abstract]   [Full Text] [Related]  

  • 9. [Components of kallikrein-kinin system in the urine of patients with glomerulonephritis].
    Paskhina TS; Poliantseva LR; Platonova LV; Levina GO
    Vopr Med Khim; 1990; 36(4):62-9. PubMed ID: 2173275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diurnal variation in water, sodium and potassium excretion in primary glomerulonephritic patients and its relation to diurnal kallikrein excretion.
    Chen YM; Tsai TJ; Chang PI; Hsieh BS; Chen WY; Yen TS
    J Formos Med Assoc; 1990 Dec; 89(12):1052-6. PubMed ID: 1982672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total and kallikrein arginine esterase activities in the urine of salt-hypertensive susceptible and resistant rats.
    Sustarsic DL; McPartland RP; Rapp JP
    Hypertension; 1980; 2(6):813-20. PubMed ID: 7007238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary kallikrein excretion is related to renal function change and inflammatory status in chronic kidney disease patients receiving angiotensin II receptor blocker treatment.
    Chiang WC; Lin SL; Chen YM; Wu KD; Tsai TJ
    Nephrology (Carlton); 2008 Jun; 13(3):198-203. PubMed ID: 18315702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal kallikrein and PGE in the exaggerated fractional Na excretion in patients with chronic renal failure.
    Abe K; Haruyama T; Sato M; Imai Y; Yasujima M; Seino M; Chiba S; Hiwatari M; Kasai Y; Tajima J; Itoh S; Yoshinaga K
    Adv Exp Med Biol; 1983; 156 (Pt B)():977-84. PubMed ID: 6344585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
    Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K
    Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of urinary fibrin/fibrinogen degradation products (FDP) measured by highly sensitive ELISA method in various renal diseases].
    Shibata T; Sumie A; Ishii T; Tomo T; Magari Y; Sato J; Yasumori R; Nasu M
    Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):687-94. PubMed ID: 8377281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The participation of the kallikrein-kinin system in edema formation in glomerulonephritis].
    Kaiukov IG; Kucher AG
    Urol Nefrol (Mosk); 1991; (1):51-4. PubMed ID: 1858208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between spot urine and overnight urine in the estimation of 24-hour excretion of urine protein, sodium and kallikrein.
    Tsai TJ; Chen YM; Hsieh BS; Chen WY
    J Formos Med Assoc; 1991 Aug; 90(8):755-9. PubMed ID: 1683368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sodium depletion on urinary excretion of active and inactive kallikrein in glomerulonephritic patients.
    Tsai TJ; Chen YM; Yeah FT; Hsieh BS; Chen WY; Yen TS
    J Formos Med Assoc; 1991 Jan; 90(1):105-8. PubMed ID: 1679103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies on kallikrein activity in diabetic patient with hypertension caused by nephropathy].
    Kunii N
    Nihon Jinzo Gakkai Shi; 1989 Jan; 31(1):39-48. PubMed ID: 2746999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excretion of Tamm-Horsfall glycoprotein in renal disease.
    Lynn KL; Marshall RD
    Clin Nephrol; 1984 Nov; 22(5):253-7. PubMed ID: 6518675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.